SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network is trending due to a recent AI-related partnership and exceptionally high short interest, sparking intense speculation among traders. The community is actively debating the potential for a substantial short squeeze, drawing comparisons to historical parabolic runs, as investors weigh the dramatic upward momentum against the risks of a significant pullback.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending due to reports of a substantial government investment, acquiring an equity stake and providing significant financing to bolster domestic critical mineral production for national security. This development has sparked highly bullish sentiment among the community, with many anticipating substantial price gains and a short squeeze, while also prompting discussions around valuation and market influences within the rare earth sector.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is experiencing explosive momentum, propelled by a combination of a weakening dollar, rising geopolitical tensions, and increasing industrial demand for silver. The community is sharply divided, with bulls anticipating a continued short squeeze to new highs while bears warn of an unsustainable 'blow-off top' ripe for a significant correction or rotation into copper. This intense debate also highlights discussions around the fundamental difference between physical silver and paper assets.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending due to significant news, including its rumored acquisition of SkyWater Technology, its official inclusion in the Missile Defense Agency's SHIELD/Golden Dome initiative, and the strategic hiring of a former DOD CIO. The community is actively discussing these developments, viewing them as pivotal for IonQ's role in next-gen defense and a major step in the quantum computing race, amidst ongoing debates about its valuation and sector volatility.

Skywater Technology, Inc. is a holding company. It engages in the provision of semiconductor development, manufacturing services, and packaging services. The company was founded on October 3, 2016 and is headquartered in Bloomington, MN.

SkyWater Technology Inc

SkyWater Technology is a major talking point following strong earnings and an optimistic long-term revenue outlook, which has been reinforced by a recent analyst upgrade. The community is abuzz with its strategic importance as a domestic foundry, focusing on quantum computing, aerospace, defense, and advanced packaging amid U.S. chip reshoring efforts. Investors are actively debating the company's significant growth potential, with many viewing recent price dips as prime opportunities.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as a key player in the critical minerals sector after the U.S. National Oceanic and Atmospheric Administration (NOAA) streamlined deep-sea mining regulations, enabling the company to submit a consolidated application for an expanded recovery permit. The community is highly bullish, anticipating rapid permit approval due to national security imperatives to secure essential metals and a potential short squeeze on significant short interest. This move is seen as substantially de-risking TMC's path to future production, aligning with a broader rally in rare earths and critical mineral stocks.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is heavily discussed as the market anticipates key 3-year data from its pivotal ELEVIDYS gene therapy study, with community members debating whether the results will trigger a significant short squeeze or a "sell the news" reaction. Investors are also closely watching for updates on the company's broader gene therapy pipeline, including upcoming data from its siRNA programs for other rare neuromuscular diseases, amidst ongoing discussions about the stock's long-term valuation and high short interest.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is actively trending as its dedicated community emphasizes its unique multi-chain presence across Solana, BNB, Cronos, and Ethereum (Base), powered by Layerzero technology. Investors are highlighting its deflationary burn mechanism and organic, cult-like following as key differentiators within the meme coin sector.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Mannkind is trending due to significant community discussion and anticipation following the FDA's recent approval of an updated Afrezza label, offering crucial starting dose guidance for patients switching insulin therapies. This update is widely seen as a major catalyst to simplify use and accelerate adoption, with investors actively debating its impact on future sales and broader market penetration for the inhaled insulin. While some express long-term optimism regarding Afrezza's expanded indications and the company's diverse pipeline, others remain cautious given historical performance and ongoing market skepticism.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is attracting significant attention following its Breakthrough Therapy Designation for Pemvidutide in MASH and recent positive 48-week clinical data, fueling community speculation around a major partnership or acquisition. While many view Pemvidutide as a "best-in-class" asset in the competitive MASH and obesity markets, others remain cautious, pointing to past trial outcomes and concerns over potential dilution. The broader discussion centers on whether the company's dual-agonist therapy is poised for a significant re-rating given strategic interest within the sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

ESYS
Elecsys Corp.

Feed

News

Sentiment

Fundamentals

Info

Latest ESYS News

ESYSElecsys Corp.